Secondary Pharmacological Prevention of Coronary Artery Disease among Patients Submitted to Clinical Management, Percutaneous Coronary Intervention, or Coronary Artery Bypass Graft Surgery

Secondary prevention is recommended for patients with evidence of coronary artery disease (CAD) regardless of the indication for treatment by coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention (PCI). This study evaluated whether clinical treatment, PCI or CABG had an i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Arquivos brasileiros de cardiologia 2023-02, Vol.120 (2), p.e20220403-e20220403
Hauptverfasser:	Lucca, Marcelo B, Fuchs, Felipe C, Almeida, Adriana S, Wainstein, Marco V, Fuchs, Flavio D, Fuchs, Sandra C
Format:	Artikel
Sprache:	eng
Schlagworte:	Coronary Angiography Coronary Artery Bypass - adverse effects Coronary Artery Disease - drug therapy Coronary Artery Disease - surgery Humans Percutaneous Coronary Intervention - adverse effects Secondary Prevention Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!